Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

EXPLAINED: Atai life sciences s return on capital employed insights | Vintage Vibes

ATAI Life Sciences (NASDAQ:ATAI) brought in sales totaling $230.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 194.78%, resulting in a loss of $93.27 million. In Q3, ATAI Life Sciences brought in $266.00 thousand in sales but lost $31.64 million in earnings.

Why Is ROCE Significant?

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.